Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
In 2024, a study looking back at people who took GLP-1 agonists found that they were well tolerated and effective for weight loss in people living with Crohns disease and ulcerative colitis
Collectively, these advancements are reshaping treatment protocols and boosting the role of GLP-1 therapies in chronic disease management
For those who experienced these side effects while on the medication, discontinuing it might lead to a gradual resolution of these symptoms
Result Literature search After searching three databases, including PubMed, Embase, and Cochrane Library, a total of 1127 reports were identified (368 from PubMed, 630 from Embase, and 129 from Cochrane Library)
Those same providers' specific credentials (degree, school, licensing board) were not displayed on the pages reviewed and are not stated here as fact
